FDA Bans Bextra, Issues Black Box Edict For NSAIDs

The FDA may indeed be wising up about the toxic effects of nonsteroidal anti-inflammatory drugs, better known as NSAIDs. Today, the federal agency pulled Bextra from the American market (the European Union did the same) and wants all NSAIDs -- Celebrex the best known of the bunch after the currently banned Vioxx -- to carry a black-box warning cautioning users about an increased risk of cardiovascular side effects.

According to drugmaker Pfizer, the FDA pulled Bextra due to serious and sometimes fatal skin reactions, just one of the many problems associated with this toxic drug I warned you about four years ago.

The agency also asked drugmakers that sell over-the-counter NSAIDs -- think Aleve, aspirin and ibuprofen -- to revise their labels to clarify the risks of cardiovascular problems, rare and serious skin problems and gastrointestinal bleeding.

If you're still taking one of those NSAIDs that's been pulled from the market or received a black box warning, there's no need to panic, particularly when there's far safer options that are healthier for your body, and particularly your heart.

USA Today April 7, 2005

Click Here and be the first to comment on this article
Post your comment